Imgn stock forecast.

Average Volume (3M) 4.65M. Market Cap. $4.20B. Enterprise Value $3.68B. Total Cash (Recent Filing) $605.50M. Total Debt (Recent Filing) $84.33M. Price to Earnings (P/E) -52.2. Beta 0.71. Next Earnings.

Imgn stock forecast. Things To Know About Imgn stock forecast.

ImmunoGen, Inc. (IMGN) Stock Price, News, Quote & History - Yahoo Finance Finance Home Watchlists My Portfolio Markets News Videos Yahoo Finance Plus Crypto Sectors U.S. markets close in 3...Here are some of Thursday's biggest stock movers: Biggest stock gainers. ImmunoGen (NASDAQ:IMGN) skyrocketed 81% after AbbVie agreed to acquire a cancer drugmaker for $10.1B, adding Elahere, a ...Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen closed nearly 83% higher Thursday, while AbbVie’s stock ...ImmunoGen, Inc. expects to convert the Accelerated Approval of its drug Elahere to Full Approval in 1H24. Find out why IMGN stock is a Strong Buy.ImmunoGen (IMGN) delivered earnings and revenue surprises of 20.69% and 132.98%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Quite a few analysts cover the stock, so you could look into forecast growth quite easily. Insider Ownership Of ImmunoGen While the precise definition of an insider can be subjective, almost ...

Oct 26, 2023 · With the interplay of data, predictions, and real-time performance, ImmunoGen's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale. With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

The consensus price target of analysts on Wall Street is $28.57, which implies a decrease of -2.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $19.00 and $31.26 respectively. As a result, IMGN is trading at a discount of -6.51% off the target high and 35.26% off the low.A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Immunogen, Inc.’s current trading price is -0.41% away from its 52-week high, while its distance from the 52-week low is 713.31%. The stock’s price range for this time frame has been between $3.61 and $29.44.Average Volume (3M) 4.65M. Market Cap. $4.20B. Enterprise Value $3.68B. Total Cash (Recent Filing) $605.50M. Total Debt (Recent Filing) $84.33M. Price to Earnings (P/E) -52.2. Beta 0.71. Next Earnings.Analyst projections state that FLEX is forecast to be at a low of $31.00 and a high of $35.00. In order for the stock price to hit the forecast high, the stock would need to plunge -34.93% from its current level, while the stock would need to crash -19.51% from its current level to reach the projected low. Flex Ltd (FLEX) estimates and forecasts

IMGN Stock Performance on September 13, 2023. On September 13, 2023, IMGN stock showed positive performance, opening at $16.00 and reaching a high of $16.43 during the day. The stock had a previous close of $15.44, indicating an increase in value. The trading volume for the day was 178,127 shares. IMGN has a market capitalization of $3.9 billion.

Find the latest Earnings Report Date for ImmunoGen, Inc. Common Stock (IMGN) at Nasdaq.com.

According to the issued ratings of 9 analysts in the last year, the consensus rating for ImmunoGen stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for IMGN. The average twelve-month price prediction for ImmunoGen is $22.00 with a high price target of $28.00 and a low price target of $16.00.For the full year 2021, the company reported $6.6 billion in total revenue, a gain of 36% year-over-year. New stocks with strong growth curves are sure to attract Griffin's attention. His firm ...Nov 1, 2023 · ImmunoGen will release figures for the most recent quarter on November 2. Forecasts of 13 analysts expect earnings of $0.044 per share compared to losses of $0.310 per share from the same quarter ... According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Learn about ImmunoGen, Inc. (IMGN) stock's management team. Comprehensive performance, salary and tenure analysis for the CEO, ... (NASDAQ:IMGN) Forecasts Aug 06. President recently sold US$17m worth of stock Aug 06. Immunogen, Inc. Reaffirmes Revenue Guidance for 2023. Aug 02. Forecast breakeven date moved forward to 2024 …

Find the latest Earnings Report Date for ImmunoGen, Inc. Common Stock (IMGN) at Nasdaq.com.The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.Nov 28, 2023 · Analyst projections state that IMGN is forecast to be at a low of $14.00 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -73.27% from its current level, while the stock would need to crash 13.37% from its current level to reach the projected low. Charley Grant. , Reporter. Big pharma’s $10.1 billion deal splash is giving biotech stocks a lift. AbbVie, which sells widely-used drugs like Humira and Skyrizi, said Thursday it plans to buy ...May 5, 2021 · The average ImmunoGen stock forecast 2023 represents a 2.43% increase from the last price of $16.0599994659424. For ImmunoGen stock forecast for 2024, 12 predictions are offered for each month of 2024 with average ImmunoGen stock forecast of $13.61, a high forecast of $16.55, and a low forecast of $9.22. The average ImmunoGen stock forecast ... According to analyst projections, ASXC’s forecast low is $2.00 with $2.00 as the target high. To hit the forecast high, the stock’s price needs a -769.57% plunge from its current level, while the stock would need to soar -769.57% for it to hit the projected low. Asensus Surgical Inc (ASXC) estimates and forecastsImmunoGen (IMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The of IMGN is 0.45, indicating a bullish outlook. Fintel reports that on December 1, 2023, Barclays downgraded their outlook for Immunogen (NASDAQ:IMGN) from Overweight to Equal-Weight . Analyst ...Over the past four weeks, IMGN has gained 89.4%. The company is currently ranked a Zacks Rank #2 (Buy), another strong indication the stock could move even higher. Looking at IMGN's earnings ...

Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Ford (NYSE: F) stock declined 2.6% after the auto giant cut its full-year earnings forecast, saying the U.S. auto workers' strike has led to a $1.7 billion hit to its profit and lost production of ...4 Growth Stocks, 4 Value Stocks to Buy Each stock offers a different opportunity in this uncertain market outlook. Jeff Reeves and Jordan Schultz Nov. 27, 2023The average ImmunoGen stock forecast 2023 represents a 2.43% increase from the last price of $16.0599994659424. For ImmunoGen stock forecast for 2024, 12 predictions are offered for each month of 2024 with average ImmunoGen stock forecast of $13.61, a high forecast of $16.55, and a low forecast of $9.22. The average ImmunoGen stock forecast ...The average price target for Pliant Therapeutics is $47.64. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $63.00 ,the lowest forecast is $34.00. The average price target represents 261.73% Increase from the current price of $13.17.According to . 9 Wall Street analysts that have issued a 1 year IMGN price target, the average IMGN price target is $22.67, with the highest IMGN stock price forecast at …

He started stock trading from his Harvard dorm room, and founded the Citadel fund in 1990. Today, Citadel has over $43 billion in assets under management. A look at the last couple of years.

8 brokers have issued 12-month price objectives for TG Therapeutics' stock. Their TGTX share price targets range from $6.00 to $41.00. On average, they predict the company's stock price to reach $22.25 in the next twelve months. This suggests a possible upside of 69.7% from the stock's current price.

As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Immunogen Stock Prediction. NOV. 37According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...U.S. stock index futures on Thursday pointed to a higher open, after economic data showed a moderation in the Federal Reserve's favorite inflation gauge. On the final day of November, markets are ...ImmunoGen stock gains 7% amid Q3 report, positive study results SA News Thu, Nov. 02 7 Comments ImmunoGen GAAP EPS of $0.10 beats by $0.06, revenue of $113.4M beats by $8.19M28.90R USD −0.4217 −1.44%. The 12 analysts offering 1 year price forecasts for ImmunoGen, Inc. have a max estimate of 31.26 and a min estimate of 19.00.Turning to the calls side of the option chain, the call contract at the $17.00 strike price has a current bid of $3.00. If an investor was to purchase shares of IMGN stock at the current price ...

Analyst projections state that IMGN is forecast to be at a low of $14.00 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -73.27% from its current level, while the stock would need to crash 13.37% from its current level to reach the projected low.ImmunoGen (IMGN) closed the last trading session at $5.20, gaining 38.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...Nov 21, 2023 · The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below. Instagram:https://instagram. best gun owner insurancemo stock forecastlennatusa bank stock Dec 1, 2023 · The consensus price target of analysts on Wall Street is $28.57, which implies a decrease of -2.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $19.00 and $31.26 respectively. As a result, IMGN is trading at a discount of -6.51% off the target high and 35.26% off the low. Average Volume (3M) 4.65M. Market Cap. $4.20B. Enterprise Value $3.68B. Total Cash (Recent Filing) $605.50M. Total Debt (Recent Filing) $84.33M. Price to Earnings (P/E) -52.2. Beta 0.71. Next Earnings. self employed mortgage lendinghow to buy softbank stock View the latest Immunogen Inc. (IMGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.Oct 15, 2020 · The Immunogen stock forecast is 20.145677807197 USD for 2024 November 27, Wednesday; and 43.674 USD for 2028 November 27, Monday with technical analysis. Immunogen (IMGN) stock price prediction is 20.145677807197 USD. blackberry stokc When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.ImmunoGen (NASDAQ: IMGN) is one of the better biotech stocks that you can buy today. The company’s stock is up 215% in 2023, and that’s even after a slight dip over the last two months ...Currently, the Dow is -8 points, the S&P 500 is -7, the Nasdaq -39 points and the small-cap Russell 2000 -2. Only the Nasdaq is down over the past week of trading, with the blue-chip Dow leading ...